ATBECHDEDKESFRGBGRITLILUNLSE..PTIESI..LVFIRO........................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0862437A119980909EP96938215.01996111119980325enenen1995002375219951121GB1998090919983719980909199837

A61K 9/ 22 A I

A61K 9/ 20 A I

A61K 9/ 28 A I

A61K 31/ 505 A I

A61K 31/ 517 A I

A61K 47/ 30 A I

A61K 47/ 38 A I

enPHARMACEUTICAL FORMULATIONSfrFORMULATIONS PHARMACEUTIQUESdeARZNEIMITTELPfizer Research and Development Company, N.V./S.A.La Touche House, International Financial Services CentreDublin 1IEPfizer LimitedRamsgate RoadSandwich Kent CT13 9NJGBMACRAE, Ross, JamesPfizer Central Research Ramsgate RoadSandwich Kent CT13 9NJGBSMITH, Janet, SarahPfizer Central Research Ramsgate RoadSandwich Kent CT13 9NJGBHayles, James RichardPfizer Limited, Patents Department, Ramsgate RoadSandwich Kent CT13 9NJGBATBECHDEDKESFIFRGBGRIEITLILUNLPTSELV19980325RO19980325SI19980325EP199600502019961111enWO199701881419970529199723